GlassScriptPhysician profile
Tabitha B Staradumsky
NPI 1841730132
$1,312.19
in general payments reported to CMS, 2019-2025
25 companies · $13.77 in 2025
The $13.77 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $159 · 2022: $735 · 2023: $388 · 2024: $17.13 · 2025: $13.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $419.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $418.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $181.17 | 2021-2023 | |
| Glaxosmithkline, LLC. | $158.77 | 2022-2023 | Shingrix |
| Novo Nordisk INC | $122.92 | 2021-2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $86.13 | 2022 | |
| Sanofi-Aventis U.S. LLC | $81.57 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $76.19 | 2022-2023 | Gardasil 9 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $69.90 | 2021-2023 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $64.81 | 2022-2023 | |
| Lilly USA, LLC | $55.29 | 2021-2022 | |
| Pfizer INC. | $50.28 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $50.01 | 2023 | Spravato |
| Antares Pharma, INC. | $45.06 | 2022-2023 | Nocdurna, Xyosted, Tlando |
| Abbott Laboratories | $43.85 | 2022-2023 | Freestyle Libre |
| Astrazeneca Pharmaceuticals LP | $38.84 | 2022-2025 | Airsupra |
| Bausch Health US, LLC | $36.40 | 2022-2023 | Aplenzin |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $20.24 | 2022 | |
| Astellas Pharma US INC | $17.93 | 2023 | Myrbetriq |
| Paratek Pharmaceuticals, INC. | $15.77 | 2023 | Nuzyra |
| Amgen INC. | $15.57 | 2022 | |
| Eisai INC. | $15.54 | 2021 | |
| Ironshore Pharmaceuticals INC. | $15.33 | 2022 | |
| Currax Pharmaceuticals LLC | $14.31 | 2022 | |
| Idorsia Pharmaceuticals US INC | $12.55 | 2022 | |
| Neos Therapeutics, LP | $12.02 | 2022 | |
| Amneal Pharmaceuticals LLC | $11.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tabitha Staradumsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.